<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7293477/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Vaccines under development based on Protein Subunit for COVID-19 according to the WHO as of April 20, 2020 (adapted from (20).</p>
 </caption>
 <thead>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="0-0-.">platform</th>
   <th colspan="1" rowspan="1" id="0-1-."/>
   <th align="left" colspan="1" rowspan="1" id="0-2-.">developer</th>
   <th align="left" colspan="1" rowspan="1" id="0-3-.">Phase of study</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Drosophila S2 insect cell expression system VLPs</td>
   <td align="left">ExpreS2ion</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S protein</td>
   <td align="left">WRAIR/USAMRIID</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S-Trimer</td>
   <td align="left">Clover Biopharmaceuticals Inc./GSK</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Peptide</td>
   <td align="left">Vaxil Bio</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S protein</td>
   <td align="left">AJ Vaccines</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Ii-Key peptide</td>
   <td align="left">Generex/EpiVax</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S protein</td>
   <td align="left">EpiVax/Univ. of Georgia</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S protein (baculovirus production)</td>
   <td align="left">Sanofi Pasteur</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Full length S trimers/ nanoparticle + Matrix M</td>
   <td align="left">Novavax</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">gp-96 backbone</td>
   <td align="left">Heat Biologics/Univ. Of Miami</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Molecular clamp stabilized Spike protein</td>
   <td align="left">University of Queensland/GSK</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S1 or RBD protein</td>
   <td align="left">Baylor College of Medicine</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Subunit</td>
   <td align="left">Subunit protein, plant produced</td>
   <td align="left">iBio/CC-Pharming</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Subunit</td>
   <td align="left">VIDO-InterVac, University of Saskatchewan</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Adjuvanted microsphere peptide</td>
   <td align="left">University of Saskatchewan</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">Full-length Spike, S1, RDB, nucleocapsid 
    <br/>Formulated with adjuvants /or fused with Fc 
   </td>
   <td align="left">(Novavax, Phase III) recombinant S protein (Vaxine Pty Ltd, Australia, Phase I)</td>
   <td align="left">Preclinical</td>
  </tr>
  <tr>
   <td align="left">Protein Subunit</td>
   <td align="left">S protein (adenovirus production</td>
   <td align="left">Johnson &amp; Johnson (Jansen): In partnership with Biomedical Advanced Research and Development Authority (BARDA)</td>
   <td align="left">Preclinical</td>
  </tr>
 </tbody>
</table>
